A cornucopia of new bills; Canadians support end-of-life psilocybin therapy; and tempering the hype - The Microdose
The Reagan-Udall Foundation, a non-profit created to advance the work of the U.S. Food and Drug Administration, held a two-day conference this week on current psychedelic research and clinical study design.